- Report
- February 2024
- 175 Pages
Global
From €4865EUR$5,000USD£4,168GBP
- Clinical Trials
- April 2024
- 90 Pages
Global
From €1946EUR$2,000USD£1,667GBP
- Report
- October 2023
- 84 Pages
Global
From €4768EUR$4,900USD£4,084GBP
- Report
- November 2023
- 320 Pages
Global
From €3099EUR$3,185USD£2,655GBP
€4427EUR$4,550USD£3,792GBP
- Report
- February 2024
- 250 Pages
Global
From €4865EUR$5,000USD£4,168GBP
- Report
- November 2023
- 420 Pages
Global
From €3099EUR$3,185USD£2,655GBP
€4427EUR$4,550USD£3,792GBP
- Report
- April 2024
- 183 Pages
Global
From €4768EUR$4,900USD£4,084GBP
- Clinical Trials
- January 2024
- 881 Pages
Global
From €2432EUR$2,500USD£2,084GBP
- Report
- December 2021
- 245 Pages
Global
From €2676EUR$2,750USD£2,292GBP
€5351EUR$5,500USD£4,584GBP
- Report
- October 2019
Global
From €2724EUR$2,800USD£2,334GBP
- Report
- October 2018
- 288 Pages
Global
From €4038EUR$4,150USD£3,459GBP
- Report
- April 2023
- 100 Pages
Global
From €5789EUR$5,950USD£4,959GBP
- Report
- January 2023
- 154 Pages
From €2043EUR$2,100USD£1,750GBP
€2919EUR$3,000USD£2,501GBP
- Report
- January 2023
- 229 Pages
Middle East, Africa
From €2043EUR$2,100USD£1,750GBP
€2919EUR$3,000USD£2,501GBP
- Report
- January 2023
- 152 Pages
North America
From €2043EUR$2,100USD£1,750GBP
€2919EUR$3,000USD£2,501GBP
- Report
- January 2023
- 151 Pages
Europe
From €2043EUR$2,100USD£1,750GBP
€2919EUR$3,000USD£2,501GBP
- Report
- January 2023
- 183 Pages
Asia Pacific
From €2043EUR$2,100USD£1,750GBP
€2919EUR$3,000USD£2,501GBP
- Report
- November 2022
- 291 Pages
Global
From €3099EUR$3,185USD£2,655GBP
€4427EUR$4,550USD£3,792GBP
- Report
- April 2023
- 111 Pages
Global
From €4622EUR$4,750USD£3,959GBP
- Report
- May 2020
- 111 Pages
Global
From €4622EUR$4,750USD£3,959GBP
The Malaria Drug market is a subset of the larger Infectious Diseases Drugs market. Malaria is a mosquito-borne disease caused by a parasite, and is one of the leading causes of death in the world. Malaria drugs are used to treat and prevent the disease, and are typically administered orally or intravenously. The market for malaria drugs is highly competitive, with a range of generic and branded products available. The market is driven by the increasing prevalence of malaria, as well as the need for new and improved treatments.
The market is also influenced by government policies and regulations, as well as the availability of funding for research and development. Additionally, the market is affected by the availability of new technologies, such as rapid diagnostic tests and vaccines.
Some companies in the Malaria Drug market include Novartis, GlaxoSmithKline, Sanofi, Merck, and Pfizer. Show Less Read more